Evidence supporting the use of: Paeoniflorin
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Paeoniflorin, a principal bioactive compound extracted from the root of Paeonia lactiflora (commonly known as peony), has been studied in recent years for its potential effects on osteoporosis. Preclinical studies, mainly in animal models and cellular systems, have demonstrated that paeoniflorin can inhibit osteoclast differentiation and bone resorption, as well as promote osteoblast activity and bone formation. The proposed mechanisms involve the regulation of RANKL/OPG signaling pathways, inhibition of inflammation, and antioxidative effects, all of which can contribute to improved bone metabolism and prevention of bone loss.

However, the evidence supporting paeoniflorin’s use in osteoporosis is currently limited to laboratory and animal studies. There are no well-designed clinical trials in humans that directly assess its efficacy or safety for osteoporosis prevention or treatment. While these preclinical findings are promising, they are not sufficient to establish paeoniflorin as an effective treatment for osteoporosis in clinical practice. More research, including controlled human studies, is required to confirm its therapeutic potential and to determine appropriate dosing and safety profiles.

In summary, while paeoniflorin is not a traditional remedy specifically for osteoporosis, there is growing scientific interest and preliminary evidence suggesting potential benefits. Based on current data, the evidence level for its use in osteoporosis is rated at 2 out of 5.

More about Paeoniflorin
More about Osteoporosis

Products containing Paeoniflorin

We currently have no products on Vitabase that contain this ingredient.